BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34615711)

  • 1. High-risk human papillomavirus-18 uses an mRNA sequence to synthesize oncoprotein E6 in tumors.
    García A; Maldonado G; González JL; Svitkin Y; Cantú D; García-Carrancá A; Sonenberg N; Hernández G
    Proc Natl Acad Sci U S A; 2021 Oct; 118(41):. PubMed ID: 34615711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation.
    Tang S; Tao M; McCoy JP; Zheng ZM
    J Virol; 2006 May; 80(9):4249-63. PubMed ID: 16611884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
    Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
    Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leaky scanning is the predominant mechanism for translation of human papillomavirus type 16 E7 oncoprotein from E6/E7 bicistronic mRNA.
    Stacey SN; Jordan D; Williamson AJ; Brown M; Coote JH; Arrand JR
    J Virol; 2000 Aug; 74(16):7284-97. PubMed ID: 10906182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
    Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY
    Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
    He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
    McFarlane M; MacDonald AI; Stevenson A; Graham SV
    J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
    Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
    Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol inhibits the progression of cervical cancer by suppressing the transcription and expression of HPV E6 and E7 genes.
    Sun X; Fu P; Xie L; Chai S; Xu Q; Zeng L; Wang X; Jiang N; Sang M
    Int J Mol Med; 2021 Jan; 47(1):335-345. PubMed ID: 33236130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.
    Yew CW; Lee P; Chan WK; Lim VK; Tay SK; Tan TM; Deng LW
    Cancer Res; 2011 Nov; 71(21):6696-707. PubMed ID: 21908553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of HPV E6 and E7 expression by BAF53 depletion in cervical cancer cells.
    Lee K; Lee AY; Kwon YK; Kwon H
    Biochem Biophys Res Commun; 2011 Aug; 412(2):328-33. PubMed ID: 21821000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m
    Hu C; Liu T; Han C; Xuan Y; Jiang D; Sun Y; Zhang X; Zhang W; Xu Y; Liu Y; Pan J; Wang J; Fan J; Che Y; Huang Y; Zhang J; Ding J; Yang S; Yang K
    Int J Biol Sci; 2022; 18(2):507-521. PubMed ID: 35002506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and the amounts of extracellular microvesicles released from HPV-positive cancer cells.
    Honegger A; Leitz J; Bulkescher J; Hoppe-Seyler K; Hoppe-Seyler F
    Int J Cancer; 2013 Oct; 133(7):1631-42. PubMed ID: 23526637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
    de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
    Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC; DiMaio D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microarray analysis identifies differentially expressed genes induced by human papillomavirus type 18 E6 silencing RNA.
    Min W; Wen-li M; Zhao-hui S; Ling L; Bao Z; Wen-ling Z
    Int J Gynecol Cancer; 2009 May; 19(4):547-63. PubMed ID: 19509549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease.
    Kennedy EM; Kornepati AV; Goldstein M; Bogerd HP; Poling BC; Whisnant AW; Kastan MB; Cullen BR
    J Virol; 2014 Oct; 88(20):11965-72. PubMed ID: 25100830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.
    Saidu NEB; Filić V; Thomas M; Sarabia-Vega V; Đukić A; Miljković F; Banks L; Tomaić V
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus type 18 oncoproteins exert their oncogenicity in esophageal and tongue squamous cell carcinoma cell lines distinctly.
    Boon SS; Chen Z; Li J; Lee KYC; Cai L; Zhong R; Chan PKS
    BMC Cancer; 2019 Dec; 19(1):1211. PubMed ID: 31830929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.